CHICAGO (GenomeWeb) – Early results from a prospective study by investigators at Ambry Genetics, Beth Israel Deaconess Medical Center, the University of Pittsburgh, and HonorHealth/TGen suggest that the suite of genes that carry risky mutations in some pancreatic cancer patients may be broader than generally appreciated.